Date of Completion
12-18-2010
Embargo Period
1-1-2011
Advisors
Pouran Faghri; Declan Barry
Field of Study
Allied Health
Degree
Master of Science
Open Access
Open Access
Abstract
Drug- and sex-related HIV risk behaviors and sub-optimal adherence to HIV medication regimens can jeopardize the health of HIV–infected injection drug users (IDUs) and threaten community health. Findings to date indicate that it is feasible to deliver a brief behavioral risk reduction/medication adherence group intervention to HIV-infected IDUs in a community-based setting. Being adherent to HAART or being able to successfully participate in behavioral interventions targeting adherence and harm reduction often requires a relatively high level of cognitive abilities. HIV infection and substance abuse are known to independently affect the central nervous system and this can result in neuro-cognitive impairment. In combination, their effects can be even more profound and this is directly relevant to intervention development because a significant number of people living with HIV/AIDS have a positive history of substance abuse. AIM: To evaluate if changes in information, motivation and behavior skills (IMB) with respect to medication adherence, sex- and drug-risk behavior outcomes is predicted by cognitive impairment following the brief 4-session Community-Friendly Health Recovery Program for HIV-infected Drug Users (CHRP+). Findings suggest that it may be helpful to specifically tailor such behavioral interventions to accommodate cognitive impairment.
Recommended Citation
Ezeabogu, Ifeoma O., "The Influence of Neurocognitive Impairment on Treatment Outcomes among Drug-involved People Living with HIV/AIDS" (2010). Master's Theses. 31.
https://digitalcommons.lib.uconn.edu/gs_theses/31
Major Advisor
Michael Copenhaver